Journal article icon

Journal article

Decentralised clinical trials in multiple sclerosis research

Abstract:

Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before their introduction into clinical practice. Trials have been evolving to improve the robustness of their designs and the efficiency of their conduct. Advances in digital and mobile technologies in recent years have facilitated this process and the first RCTs with decentralised elements became possible. Decentralised clinical trials (DCT...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1177/13524585221100401

Authors


More by this author
Role:
Author
ORCID:
0000-0001-9271-346X
More by this author
Role:
Author
ORCID:
0000-0002-8225-8747
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
Publisher:
SAGE Publications
Journal:
Multiple Sclerosis Journal More from this journal
Volume:
29
Issue:
3
Pages:
317 - 325
Publication date:
2022-06-23
Acceptance date:
2022-04-19
DOI:
EISSN:
1477-0970
ISSN:
1352-4585
Pmid:
35735014
Language:
English
Keywords:
Pubs id:
1266898
Local pid:
pubs:1266898
Deposit date:
2022-08-09

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP